Home/Filings/4/0000950170-25-010137
4//SEC Filing

DOYLE THOMAS JAMES 4

Accession 0000950170-25-010137

CIK 0001422143other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 8:54 PM ET

Size

10.1 KB

Accession

0000950170-25-010137

Insider Transaction Report

Form 4
Period: 2025-01-28
DOYLE THOMAS JAMES
SVP, Finance & Accounting
Transactions
  • Sale

    Common Stock

    2025-01-28$7.87/sh699$5,50289,315 total
  • Sale

    Common Stock

    2025-01-28$7.87/sh1,122$8,83288,193 total
  • Sale

    Common Stock

    2025-01-28$7.87/sh2,241$17,64190,901 total
  • Sale

    Common Stock

    2025-01-28$7.87/sh887$6,98290,014 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    500
Footnotes (4)
  • [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
  • [F2]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.
  • [F3]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
  • [F4]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.

Documents

1 file

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1
  • filerCIK 0001910331

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 8:54 PM ET
Size
10.1 KB